PlainRecalls
FDA Devices Moderate Class II Terminated

Terumo CDI 101 Hematocrit/Oxygen Saturation Monitoring System. Monitors blood/oxygen saturation, hematocrit and hemoglobin levels.

Reported: February 20, 2013 Initiated: November 1, 2010 #Z-0802-2013

Product Description

Terumo CDI 101 Hematocrit/Oxygen Saturation Monitoring System. Monitors blood/oxygen saturation, hematocrit and hemoglobin levels.

Reason for Recall

Inaccurate readings. Software contains unused (turned off) accuracy correction factors for slope (gain) and offset (bias) for Hematocrit/Saturation calculations. The accuracy on any cuvette size did not meet the specifications.

Details

Units Affected
622 units
Distribution
Worldwide Distribution.
Location
Ann Arbor, MI

Frequently Asked Questions

What product was recalled?
Terumo CDI 101 Hematocrit/Oxygen Saturation Monitoring System. Monitors blood/oxygen saturation, hematocrit and hemoglobin levels.. Recalled by Terumo Cardiovascular Systems Corporation. Units affected: 622 units.
Why was this product recalled?
Inaccurate readings. Software contains unused (turned off) accuracy correction factors for slope (gain) and offset (bias) for Hematocrit/Saturation calculations. The accuracy on any cuvette size did not meet the specifications.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 20, 2013. Severity: Moderate. Recall number: Z-0802-2013.